Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-HBV Placenta Transfer Factor Injection in HBeAg Positive Chronic Hepatitis B
NCT02412319Phase 4Unknown
- Sponsor
- China Shenwei Pharmaceutical Group
- Start
- Oct 2014
- Primary completion
- Dec 2016
- Modality
- Peptides
01
Overview
A Phase 4 trial of anti-hepatitis B virus placenta transfer factor in Chronic Hepatitis B (CHB), sponsored by China Shenwei Pharmaceutical Group. Status: unknown.
02
Drugs
anti-hepatitis B virus placenta transfer factor
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02412319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02412319.